Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LiCALS: Randomised placebo-controlled trial of lithium carbonate in ALS
2008-006891-31Phase 4Completed
- Sponsor
- King's College London
- Start
- Jul 2010
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in amyotrophic lateral sclerosis (ALS) comparing Lithium carbonate with Placebo (2 arms). Primary endpoint: Survival at 18 months. Started Jul 2010; status: completed.
02
Drugs
lithium carbonate
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on 2008-006891-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006891-31.